Australia markets closed

60 Degrees Pharmaceuticals, Inc. (SXTP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.2820+0.0070 (+2.55%)
At close: 04:00PM EDT
0.2815 -0.00 (-0.18%)
Pre-market: 08:28AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.31M
Enterprise value 10.43M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.04
Price/book (mrq)N/A
Enterprise value/revenue 29.56
Enterprise value/EBITDA 22.95

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-93.97%
S&P500 52-week change 326.24%
52-week high 38.6500
52-week low 30.2010
50-day moving average 30.2627
200-day moving average 30.5353

Share statistics

Avg vol (3-month) 3486.51k
Avg vol (10-day) 3811.8k
Shares outstanding 512.21M
Implied shares outstanding 612.21M
Float 88.98M
% held by insiders 123.67%
% held by institutions 14.09%
Shares short (15 May 2024) 488.93k
Short ratio (15 May 2024) 40.4
Short % of float (15 May 2024) 40.80%
Short % of shares outstanding (15 May 2024) 40.73%
Shares short (prior month 15 Apr 2024) 4130.7k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -194.38%
Operating margin (ttm)-911.51%

Management effectiveness

Return on assets (ttm)-43.34%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)378.2k
Revenue per share (ttm)0.06
Quarterly revenue growth (yoy)580.60%
Gross profit (ttm)N/A
EBITDA -5.49M
Net income avi to common (ttm)-853.05k
Diluted EPS (ttm)-0.0600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.89M
Total cash per share (mrq)0.24
Total debt (mrq)158.23k
Total debt/equity (mrq)2.22%
Current ratio (mrq)7.16
Book value per share (mrq)-0.23

Cash flow statement

Operating cash flow (ttm)-5.27M
Levered free cash flow (ttm)-3.04M